ReWalk Robotics, an Israeli maker of recently-approved exoskeletons that enable paraplegics to walk, raised $36 million by offering 3.0 million shares at $12, below the range of $14 to $16. ReWalk Robotics plans to list on the NASDAQ under the symbol RWLK. Barclays and Jefferies acted as joint bookrunners on the deal.
